Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies

StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria expanded, about 5 words
    • Study description expanded, about 4 words
  2. 5 versions Re-verified since Aug 28, 2023, no change to tracked fieldsv28-v32
  3. Primary and study completion dates: Jan 2023 to Jan 2033v27
  4. Start date: Aug 2004 to Aug 9, 2004v26
  5. 2 versions Re-verified since Jul 1, 2020, no change to tracked fieldsv24-v25
Show 22 earlier versionsHide 22 earlier versions
  1. Trial status: Active, Not Recruiting to Recruiting
    • Primary and study completion dates: Jan 2020 to Jan 2023
    • Site details revised
    v23
  2. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v22
  3. 6 versions Re-verified since Apr 22, 2014, no change to tracked fieldsv16-v21
  4. Study Status, Outcome Measures, Contacts/Locationsv15
  5. 3 versions Re-verified since Nov 11, 2010, no change to tracked fieldsv12-v14
  6. Site contact updatedv11
  7. 2 versions Re-verified since Mar 12, 2009, no change to tracked fieldsv9-v10
  8. Enrollment target: 600 to 1500
    • Primary and study completion dates: Aug 2009 to Jan 2020
    v8
  9. Site contact updatedv7
  10. Primary and study completion dates: Aug 2009v6
  11. Re-verified, no change to tracked fieldsv5
  12. Enrollment target: 475 to 600v4
  13. Re-verified, no change to tracked fieldsv3
  14. Eligibility criteria shortened, about 4 wordsv2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to investigate possible genetic factors that contribute to the development of lymphomas. The databank will be used to determine whether familial lymphomas have unique genetic characteristics different from sporadic lymphomas and to attempt to identify a gene that confers an increased risk of lymphoma.
Trial Details
NCT Number NCT00131014
Lead Sponsor Dana-Farber Cancer Institute
Conditions
(from sponsor)		 Non-Hodgkin's Lymphoma, Hodgkin's Disease, Leukemia, Lymphocytic, Chronic, Lymphoproliferative Disorders
Related terms Hodgkin Disease, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders
Enrollment 1,500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov